Human chorionic gonadotrophin treatment prior to microdissection testicular sperm extraction in non-obstructive azoospermia

Human Reproduction

Volumn 27, Issue 2, 2012, Pages 331-339

  Shiraishi, Koji ^a   Ohmi, Chietaka ^b   Shimabukuro, Tomoyuki ^b   Matsuyama, Hideyasu ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UBE INDUSTRIES LTD   (Japan)

Author keywords

hormonal therapy; microdissection testicular sperm extraction; non obstructive azoospermia

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; GONADOTROPIN; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; TESTOSTERONE;

ACNE; ADULT; ARTICLE; AZOOSPERMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FOLLITROPIN BLOOD LEVEL; GYNECOMASTIA; HISTOLOGY; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; LUTEINIZING HORMONE BLOOD LEVEL; MALE; MICRODISSECTION; NON OBSTRUCTIVE AZOOSPERMIA; NONOBSTRUCTIVE AZOOSPERMIA; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; TESTICULAR SPERM EXTRACTION; TESTOSTERONE BLOOD LEVEL;

EID: 84855875838     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/der404     Document Type: Article

References (20)

1. Aggarwal A, Misro M, Maheshwar A, Sehgal N, Nandan D. Adverse effects associated with persistent stimulation of Leydig cells with hCG in vitro. Mol Reprod Dev 2009;76:1076-1083.
2. Bergh A, Damber JE. Vascular control in testicular physiology. In: de Krester D (ed). Molecular Biology of the Male Reproductive System. San Diego: Academic Press Inc., 1993, 439-448.
3. Efesoy O, Cayan S, Akbay E. The efficacy of recombinant human follicle-stimulating hormone in the treatment of various types of male-factor infertility at a single university hospital. J Androl 2009;30:679-684.
4. Foresta C, Bettella A, Spolaore D, Merico M, Rossato M, Ferlin A. Suppression of the high endogenous levels of plasma FSH in infertile men are associated with improved Sertoli cell function as reflected by elevated levels of plasma inhibin B. Hum Reprod 2004;19:1431-1437.
5. Keenan DM, Veldhuis JD. Divergent gonadotropin-gonadal dose-responsive coupling in healthy young and aging men. Am J Physiol 2004;286:R381-R389.
6. Madgar I, Dor J, Weissenberg R, Raviv G, Menashe Y, Levron J. Prognostic value of the clinical and laboratory evaluation in patients with nonmosaic Klinefelter syndrome who are receiving assisted reproductive therapy. Fertil Steril 2002;77:1167-1169.
7. Matthiesson KL, MnLachlan RI, O'Donnell L, Frydenberg M, Robertson DM, Stanton PG, Meachem SJ. The relative roles of follicle-stimulating hormone and luteinizing hormone in maintaining spermatogonial maturation and spermiation in normal men. J Clin Endocrinol Metab 2006;91:3962-3969.
8. McLachlan RI, Rajpert-De Meyts E, Hoei-Hansen CE, de Krester DM, Skakkebaek NE. Histological evaluation of the human testis-approaches to optimizing the clinical value of the assessment: mini review. Hum Reprod 2007;22:2-16.
9. O'Shaughnessy PJ, Verhoeven G, De Gendt K, Monteiro A, Abel MH. Direct action through the Sertoli cells is essential for androgen stimulation of spermatogenesis. Endocrinology 2010;15:2343-2348.
10. Plant TM, Marshall GR. The functional significance of FSH in spermatogenesis and the control of its secretion in male primates. Endocr Rev 2001;22:764-786.
11. Ramasamy R, Ricci JA, Palermo GD, Veeck Gosden L, Rosenwaks Z, Schlegel PN. Successful fertility treatment for Klinefelter syndrome. J Urol 2009;182:1108-1113.
12. Schlegel PN. Testicular sperm extraction: microdissection improves sperm yield with minimum tissue excision. Hum Reprod 1999;27:131-135.
13. Schlegel PN. Nonobstructive azoospermia: a revolutionary surgical approach and results. Sem Reprod Med 2009;27:165-170.
14. Selman HA, Cipollone G, Stuppia L, De Santo M, Sterzik K, El-Danasouri I. Gonadotropin treatment of an azoospermic patient with a Y-chromosome microdeletion. Fertil Steril 2004;82:218-219.
15. Shiraishi K, Ascoli M. Activation of the lutropin/choriogonadotropin receptor (LHR) in MA-10 cells leads the stimulation of classical tyrosine kinase cascades that participate in the activation of Ras and the phosphprylation of the extracellular signal regulated kinases (ERK1/2). Endocrinology 2006;147:3419-3427.
16. Shiraishi K, Ascoli M. Lutropin/choriogonadotropin stimulate the proliferation of primary cultures of rat Leydig cells through a pathway that involves activation of the ERK1/2 cascades. Endocrinology 2007;148:3214-3225.
17. Spratt DI, Carr DB, Merriam GR, Scully RE, Rao PN, Crowley WF Jr. The spectrum of abnormal patterns of gonadotropin-releasing hormone secretion in men with idiopathic hypogonadotropic hypogonadism: clinical and laboratory correlations. J Clin Endocrinol Metab 1987;64:283-291.
18. Tai P, Shiraishi K, Ascoli M. Activation of the lutropin/ choriogonadotropin receptor inhibits apoptosis of immature Leydig cells in primary culture. Endocrinology 2009;150:3766-3773.
19. Tournaye H, Verheyen G, Nagy P, Ubaldi F, Goossens A, Silber S, Van Steirteghem AC, Devroey P. Are there any predictive factors for successful testicular sperm recovery in azoospermic patients? Hum Reprod 1997;12:80-86.
20. Y mice as a model for Klinefelter syndrome: hyperactivation of Leydig cells. Endocrinology 2010;151:2898-2910.